IN2014MN01838A - - Google Patents
Info
- Publication number
- IN2014MN01838A IN2014MN01838A IN1838MUN2014A IN2014MN01838A IN 2014MN01838 A IN2014MN01838 A IN 2014MN01838A IN 1838MUN2014 A IN1838MUN2014 A IN 1838MUN2014A IN 2014MN01838 A IN2014MN01838 A IN 2014MN01838A
- Authority
- IN
- India
- Prior art keywords
- oligomeric compounds
- oligomeric
- expected
- target rna
- tricyclic nucleosides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12159716.5A EP2639238A1 (en) | 2012-03-15 | 2012-03-15 | Tricyclic nucleosides and oligomeric compounds prepared therefrom |
PCT/EP2013/055498 WO2013135900A1 (en) | 2012-03-15 | 2013-03-15 | Tricyclic nucleosides and oligomeric compounds prepared therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN01838A true IN2014MN01838A (es) | 2015-07-03 |
Family
ID=47997409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1838MUN2014 IN2014MN01838A (es) | 2012-03-15 | 2013-03-15 |
Country Status (8)
Country | Link |
---|---|
US (2) | US9249178B2 (es) |
EP (3) | EP2639238A1 (es) |
JP (2) | JP2015513561A (es) |
CN (1) | CN104321334A (es) |
AU (1) | AU2013234303B2 (es) |
CA (1) | CA2866800A1 (es) |
IN (1) | IN2014MN01838A (es) |
WO (1) | WO2013135900A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI733772B (zh) | 2016-03-14 | 2021-07-21 | 美商身體邏輯股份有限公司 | 用於合成吲哚環核鹼基結合物之組成物及方法 |
WO2018055577A1 (en) | 2016-09-23 | 2018-03-29 | Synthena Ag | Mixed tricyclo-dna, 2'-modified rna oligonucleotide compositions and uses thereof |
EP3330276A1 (en) | 2016-11-30 | 2018-06-06 | Universität Bern | Novel bicyclic nucleosides and oligomers prepared therefrom |
WO2018193428A1 (en) | 2017-04-20 | 2018-10-25 | Synthena Ag | Modified oligomeric compounds comprising tricyclo-dna nucleosides and uses thereof |
JP2020517613A (ja) * | 2017-04-20 | 2020-06-18 | シンセナ アーゲー | トリシクロdnaヌクレオシドを含む改変オリゴマー化合物およびその使用 |
WO2019142135A1 (en) * | 2018-01-19 | 2019-07-25 | Synthena Ag | Tricyclo-dna nucleoside precursors and processes for preparing the same |
EP3978608A1 (en) | 2020-10-05 | 2022-04-06 | SQY Therapeutics | Oligomeric compound for dystrophin rescue in dmd patients throughout skipping of exon-51 |
WO2022106695A1 (en) | 2020-11-23 | 2022-05-27 | Alpha Anomeric Sas | Nucleic acid duplexes |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3687808A (en) | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
US5023243A (en) | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
US5405938A (en) | 1989-12-20 | 1995-04-11 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
US5256775A (en) | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
US5264564A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
US5264562A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences, Inc. | Oligonucleotide analogs with novel linkages |
US5177198A (en) | 1989-11-30 | 1993-01-05 | University Of N.C. At Chapel Hill | Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
US5130302A (en) | 1989-12-20 | 1992-07-14 | Boron Bilogicals, Inc. | Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same |
US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
US5470967A (en) | 1990-04-10 | 1995-11-28 | The Dupont Merck Pharmaceutical Company | Oligonucleotide analogs with sulfamate linkages |
US5541307A (en) | 1990-07-27 | 1996-07-30 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
US5386023A (en) | 1990-07-27 | 1995-01-31 | Isis Pharmaceuticals | Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
US5489677A (en) | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
US5623070A (en) | 1990-07-27 | 1997-04-22 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
US5378825A (en) | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
US5223618A (en) | 1990-08-13 | 1993-06-29 | Isis Pharmaceuticals, Inc. | 4'-desmethyl nucleoside analog compounds |
US5677437A (en) | 1990-07-27 | 1997-10-14 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
US5608046A (en) | 1990-07-27 | 1997-03-04 | Isis Pharmaceuticals, Inc. | Conjugated 4'-desmethyl nucleoside analog compounds |
US5610289A (en) | 1990-07-27 | 1997-03-11 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogues |
US5618704A (en) | 1990-07-27 | 1997-04-08 | Isis Pharmacueticals, Inc. | Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling |
WO1992002534A2 (en) | 1990-08-03 | 1992-02-20 | Sterling Drug, Inc. | Compounds and methods for inhibiting gene expression |
US5214134A (en) | 1990-09-12 | 1993-05-25 | Sterling Winthrop Inc. | Process of linking nucleosides with a siloxane bridge |
US5561225A (en) | 1990-09-19 | 1996-10-01 | Southern Research Institute | Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages |
WO1992005186A1 (en) | 1990-09-20 | 1992-04-02 | Gilead Sciences | Modified internucleoside linkages |
US5792608A (en) | 1991-12-12 | 1998-08-11 | Gilead Sciences, Inc. | Nuclease stable and binding competent oligomers and methods for their use |
US5633360A (en) | 1992-04-14 | 1997-05-27 | Gilead Sciences, Inc. | Oligonucleotide analogs capable of passive cell membrane permeation |
US5434257A (en) | 1992-06-01 | 1995-07-18 | Gilead Sciences, Inc. | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
JPH08502723A (ja) | 1992-07-27 | 1996-03-26 | ハイブライドン インコーポレイテッド | オリゴヌクレオチド・アルキルホスホノチオエート |
CN1121721A (zh) | 1993-01-25 | 1996-05-01 | 海布里顿公司 | 寡核苷酸烷基膦酸酯和烷基硫代膦酸酯 |
US5476925A (en) | 1993-02-01 | 1995-12-19 | Northwestern University | Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups |
GB9304620D0 (en) | 1993-03-06 | 1993-04-21 | Ciba Geigy Ag | Compounds |
GB9304618D0 (en) | 1993-03-06 | 1993-04-21 | Ciba Geigy Ag | Chemical compounds |
EP0691977B1 (en) | 1993-03-31 | 1997-11-26 | Sanofi | Oligonucleotides with amide linkages replacing phosphodiester linkages |
US5625050A (en) | 1994-03-31 | 1997-04-29 | Amgen Inc. | Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
US5646269A (en) | 1994-04-28 | 1997-07-08 | Gilead Sciences, Inc. | Method for oligonucleotide analog synthesis |
US6426220B1 (en) | 2000-10-30 | 2002-07-30 | Isis Pharmaceuticals, Inc. | Antisense modulation of calreticulin expression |
RU2006109491A (ru) * | 2003-08-27 | 2006-08-10 | Байота, Инк. (Au) | Новые трициклические нуклеозиды или нуклеотиды в качестве терапевтических средств |
EP1853618A1 (en) * | 2005-02-28 | 2007-11-14 | Genelabs Technologies, Inc. | Tricyclic-nucleoside compounds for treating viral infections |
US8935416B2 (en) | 2006-04-21 | 2015-01-13 | Fortinet, Inc. | Method, apparatus, signals and medium for enforcing compliance with a policy on a client computer |
WO2012170347A1 (en) * | 2011-06-09 | 2012-12-13 | Isis Pharmaceuticals, Inc. | Bicyclic nucleosides and oligomeric compounds prepared therefrom |
US9400902B2 (en) | 2012-05-22 | 2016-07-26 | Trimble Navigation Limited | Multi-modal entity tracking and display |
-
2012
- 2012-03-15 EP EP12159716.5A patent/EP2639238A1/en not_active Withdrawn
-
2013
- 2013-03-15 CA CA2866800A patent/CA2866800A1/en not_active Abandoned
- 2013-03-15 AU AU2013234303A patent/AU2013234303B2/en not_active Ceased
- 2013-03-15 EP EP13712184.4A patent/EP2834257A1/en not_active Ceased
- 2013-03-15 CN CN201380025398.8A patent/CN104321334A/zh active Pending
- 2013-03-15 WO PCT/EP2013/055498 patent/WO2013135900A1/en active Application Filing
- 2013-03-15 IN IN1838MUN2014 patent/IN2014MN01838A/en unknown
- 2013-03-15 US US14/385,050 patent/US9249178B2/en not_active Expired - Fee Related
- 2013-03-15 EP EP18203872.9A patent/EP3459962A1/en not_active Withdrawn
- 2013-03-15 JP JP2014561475A patent/JP2015513561A/ja active Pending
-
2016
- 2016-01-05 US US14/987,937 patent/US20160122372A1/en not_active Abandoned
-
2018
- 2018-02-08 JP JP2018020638A patent/JP2018109015A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3459962A1 (en) | 2019-03-27 |
US20160122372A1 (en) | 2016-05-05 |
CN104321334A (zh) | 2015-01-28 |
US20150141637A1 (en) | 2015-05-21 |
AU2013234303A1 (en) | 2014-10-02 |
WO2013135900A1 (en) | 2013-09-19 |
EP2834257A1 (en) | 2015-02-11 |
CA2866800A1 (en) | 2013-09-19 |
AU2013234303B2 (en) | 2017-09-14 |
JP2015513561A (ja) | 2015-05-14 |
EP2639238A1 (en) | 2013-09-18 |
JP2018109015A (ja) | 2018-07-12 |
US9249178B2 (en) | 2016-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN01838A (es) | ||
PH12019502809A1 (en) | Substituted tricyclic compounds as fgfr inhibitors | |
JOP20180102B1 (ar) | مركب صيدلاني | |
WO2011139702A3 (en) | Modified nucleosides and oligomeric compounds prepared therefrom | |
MX2013002417A (es) | Composiciones pesticidas. | |
PH12014502697B1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
WO2014028429A3 (en) | Enzymes and polymerases for the synthesis of rna | |
PH12014501322A1 (en) | Compositions comprising c5 and c6 monosaccharides | |
WO2011153157A3 (en) | Benzoquinolone inhibitors of vmat2 | |
MY160399A (en) | Compounds, compositions, and methods for preventing metastasis of cancer cells | |
PH12014501323B1 (en) | Compositions comprising lignin | |
MX359146B (es) | Compuesto como inhibidor de señalización wnt, composición y uso de los mismos. | |
EP3087184A4 (en) | Methods and compositions for the specific inhibition of glycolate oxidase (hao1) by double-stranded rna | |
EA201590887A1 (ru) | Композиция | |
MX2011014019A (es) | Derivados de diazahomoadamantano y sus metodos de uso. | |
NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
WO2013190274A3 (en) | Biodegradable compositions | |
IN2015DN00085A (es) | ||
AU2011298391A8 (en) | Substituted N-phenethyltriazoloneacetamides and uses thereof | |
EP3456837A3 (en) | Decorin compositions and use thereof | |
IN2014CN00736A (es) | ||
PH12016502133A1 (en) | Substituted tricycle compounds as fgfr inhibitors | |
WO2013128173A3 (en) | Skincare compositions | |
WO2013045098A3 (de) | Verwendung von propanol- und propenolderivaten als antioxidantien |